181 related articles for article (PubMed ID: 17451799)
1. Eosinophilia in systemic mastocytosis: clinical and molecular correlates and prognostic significance.
Böhm A; Födinger M; Wimazal F; Haas OA; Mayerhofer M; Sperr WR; Esterbauer H; Valent P
J Allergy Clin Immunol; 2007 Jul; 120(1):192-9. PubMed ID: 17451799
[TBL] [Abstract][Full Text] [Related]
2. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
3. Systemic mastocytosis in the elderly.
Butterfield JH; Weiler CR
Am J Hematol; 2013 May; 88(5):406-8. PubMed ID: 23436294
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis, clinical features, and treatment advances in mastocytosis.
Pardanani A; Akin C; Valent P
Best Pract Res Clin Haematol; 2006; 19(3):595-615. PubMed ID: 16781490
[TBL] [Abstract][Full Text] [Related]
5. Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature.
Pardanani A; Tefferi A
Curr Opin Hematol; 2010 Mar; 17(2):125-32. PubMed ID: 20075725
[TBL] [Abstract][Full Text] [Related]
6. Systemic mastocytosis: current concepts and treatment advances.
Tefferi A; Pardanani A
Curr Hematol Rep; 2004 May; 3(3):197-202. PubMed ID: 15087068
[TBL] [Abstract][Full Text] [Related]
7. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
Hollmann TJ; Brenn T; Hornick JL
Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
[TBL] [Abstract][Full Text] [Related]
8. Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms.
Alvarez-Twose I; González-de-Olano D; Sánchez-Muñoz L; Matito A; Jara-Acevedo M; Teodosio C; García-Montero A; Morgado JM; Orfao A; Escribano L
Int Arch Allergy Immunol; 2012; 157(3):275-80. PubMed ID: 22042301
[TBL] [Abstract][Full Text] [Related]
9. Detection of the c-kit D816V mutation in systemic mastocytosis by allele-specific PCR.
Schumacher JA; Elenitoba-Johnson KS; Lim MS
J Clin Pathol; 2008 Jan; 61(1):109-14. PubMed ID: 17526803
[TBL] [Abstract][Full Text] [Related]
10. Biochemical markers predictive for bone marrow involvement in systemic mastocytosis.
Donker ML; van Doormaal JJ; van Doormaal FF; Kluin PM; van der Veer E; de Monchy JG; Kema IP; Kluin-Nelemans HC
Haematologica; 2008 Jan; 93(1):120-3. PubMed ID: 18166795
[TBL] [Abstract][Full Text] [Related]
11. Systemic mastocytosis in association with chronic lymphocytic leukemia: a rare diagnosis.
Ault P; Lynn A; Tam CS; Medeiros LJ; Keating MJ
Leuk Res; 2007 Dec; 31(12):1755-8. PubMed ID: 17521719
[TBL] [Abstract][Full Text] [Related]
12. [Mastocytosis and eosinophilic leukemia: diagnostics and classification].
Sotlar K; Valent P; Horny HP
Pathologe; 2012 Nov; 33(6):539-52. PubMed ID: 23085697
[TBL] [Abstract][Full Text] [Related]
13. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia.
Krokowski M; Sotlar K; Krauth MT; Födinger M; Valent P; Horny HP
Am J Clin Pathol; 2005 Oct; 124(4):560-8. PubMed ID: 16146815
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
Hahn HP; Hornick JL
Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.
Valent P
Blood Rev; 2009 Jul; 23(4):157-65. PubMed ID: 19246139
[TBL] [Abstract][Full Text] [Related]
16. [Systemic mastocytosis. Study of 14 cases].
García-Erce JA; Giraldo P; de Vicente P; Alvarez R; Losfablos F; Velilla J; Mayayo P; Rubio-Félix D; Giralt M
Med Clin (Barc); 1998 Oct; 111(13):499-502. PubMed ID: 9859067
[TBL] [Abstract][Full Text] [Related]
17. [Mastocytosis, classification, biological diagnosis and therapy].
Arock M
Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424
[TBL] [Abstract][Full Text] [Related]
18. The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia.
Nagai S; Ichikawa M; Takahashi T; Sato H; Yokota H; Oshima K; Izutsu K; Hangaishi A; Kanda Y; Motokura T; Chiba S; Yatomi Y; Kurokawa M
Exp Hematol; 2007 Nov; 35(11):1747-52. PubMed ID: 17976525
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotyping of mast cells: a sensitive and specific diagnostic tool for systemic mastocytosis.
van Daele PL; Beukenkamp BS; Geertsma-Kleinekoort WM; Valk PJ; van Laar JA; van Hagen PM; van der Velden VH
Neth J Med; 2009 Apr; 67(4):142-6. PubMed ID: 19581658
[TBL] [Abstract][Full Text] [Related]
20. Mastocytosis.
Metcalfe DD
Novartis Found Symp; 2005; 271():232-42; discussion 242-9. PubMed ID: 16605139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
